Heart failure patients may soon get meds through a patch instead of an IV

NCT ID NCT04846816

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tested a new patch-like device that delivers the heart failure drug furosemide under the skin. Twenty hospitalized heart failure patients received a single dose to see if it is safe and works well. The goal is to find a simpler way to give this medication without needles or IVs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

furosemide delivered via a patch infusor device

What this could lead to

If successful, this could offer a more convenient way to deliver furosemide for heart failure, potentially reducing hospital stays.

What could go wrong

This is a very early phase 1 trial with only 20 participants, so results may not apply to all patients. The device could fail or cause skin reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde

    Glasgow, Glasgow, G51 4TF, United Kingdom